Home › Funds › Royce & Associates › AGIO
Royce & Associates position in AGIO
AGIOS PHARMACEUTICALS INC · Health Care
Latest position (Q1 2024)7.34K sh
Reported value held$214.56K
Portfolio Weight0.00%
First reportedQ1 2024
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 7.34K | $214.56K | New |
Other funds holding AGIO
- BlackRock Inc 6.46M sh · $239.58M · Q2 2026
- Farallon Capital Management 5.92M sh · $219.59M · Q2 2026
- Vanguard Group 5.59M sh · $152.28M · Q4 2025
- D. E. Shaw & Co 3.11M sh · $115.30M · Q2 2026
- Geode Capital Management 1.57M sh · $58.43M · Q2 2026
- Goldman Sachs Group 1.15M sh · $42.71M · Q2 2026
- UBS Group AG 985.83K sh · $36.58M · Q2 2026
- Morgan Stanley 963.26K sh · $35.75M · Q2 2026
- Arrowstreet Capital 810.53K sh · $30.08M · Q2 2026
- AQR Capital Management 684.34K sh · $25.40M · Q2 2026
- Northern Trust Corp 554.71K sh · $20.59M · Q2 2026
- Charles Schwab Investment Management 538.13K sh · $19.97M · Q2 2026